Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

NCT05737602 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05737602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 30, 2024
Completion date
July 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorder, von hippel-lindau disease